A detailed history of Rockefeller Capital Management L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 68,205 shares of MRNA stock, worth $2.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,205
Previous 176,721 61.41%
Holding current value
$2.51 Million
Previous $21 Million 78.28%
% of portfolio
0.01%
Previous 0.06%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$63.64 - $125.14 $6.91 Million - $13.6 Million
-108,516 Reduced 61.41%
68,205 $4.56 Million
Q2 2024

Aug 12, 2024

BUY
$101.21 - $166.61 $222,459 - $366,208
2,198 Added 1.26%
176,721 $21 Million
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $381,177 - $515,439
4,465 Added 2.63%
174,523 $18.6 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $35,728 - $53,677
514 Added 0.3%
170,058 $16.9 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $1.05 Million - $1.38 Million
10,895 Added 6.87%
169,544 $17.5 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $4.53 Million - $6.13 Million
38,203 Added 31.72%
158,649 $19.3 Million
Q1 2023

May 17, 2023

BUY
$135.66 - $197.02 $266,164 - $386,553
1,962 Added 1.66%
120,446 $18.5 Million
Q4 2022

Mar 06, 2023

BUY
$118.38 - $210.04 $9.06 Million - $16.1 Million
76,551 Added 182.56%
118,484 $21.3 Million
Q3 2022

Nov 02, 2022

BUY
$118.07 - $194.18 $472,280 - $776,720
4,000 Added 10.54%
41,933 $4.96 Million
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $225,123 - $339,405
1,922 Added 5.34%
37,933 $5.42 Million
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $1.55 Million - $2.87 Million
12,222 Added 51.38%
36,011 $6.2 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $294,695 - $480,905
1,305 Added 5.8%
23,789 $6.04 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $675,241 - $1.47 Million
3,043 Added 15.65%
22,484 $8.65 Million
Q2 2021

Aug 10, 2021

SELL
$129.91 - $234.98 $457,023 - $826,659
-3,518 Reduced 15.32%
19,441 $4.57 Million
Q1 2021

May 11, 2021

BUY
$109.18 - $185.98 $197,615 - $336,623
1,810 Added 8.56%
22,959 $3.01 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $313,908 - $811,081
-4,775 Reduced 18.42%
21,149 $2.21 Million
Q3 2020

Nov 13, 2020

SELL
$54.34 - $94.85 $224,858 - $392,489
-4,138 Reduced 13.76%
25,924 $1.83 Million
Q2 2020

Aug 12, 2020

SELL
$29.67 - $80.0 $421,907 - $1.14 Million
-14,220 Reduced 32.11%
30,062 $1.93 Million
Q1 2020

May 12, 2020

BUY
$17.78 - $31.58 $784,098 - $1.39 Million
44,100 Added 24230.77%
44,282 $1.33 Million
Q4 2019

Feb 07, 2020

BUY
$13.93 - $21.28 $1,142 - $1,744
82 Added 82.0%
182 $4,000
Q3 2019

Nov 12, 2019

BUY
$12.26 - $18.07 $1,226 - $1,807
100 New
100 $2,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.